Search
for
Sort by
Research 301–330 of 1000+
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- The treatment of alopecia areata
- Alopecia Areata
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- The Role of Micronutrients in Alopecia Areata: A Review
- Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I
- Association between genetically predicted rheumatoid arthritis and alopecia areata: a two-sample Mendelian randomization study
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Alopecia Areata in 12 years old female treated with Oral Azathioprine: A case report and review
- Alopecia areata incognita: A Hypothesis
- Alopecia areta: a review
- Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients
- Non-ablative Fractional Laser as an Emerging Treatment for Alopecia Areata
- M-CSF-Stimulated CD11b+ Myeloid Cells Induce Alopecia Areata in C3H/HeJ Mice
- Alopecia Areata Update
- Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- Current and future pharmacotherapy for alopecia areata
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Alopecia Areata
- Alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Alopecia areata: An update
- Factors Associated with Severity of Alopecia Areata